Retina

Aldeyra Therapeutics will seek to make its investigational drug candidate ADX-2191 available to patients with primary vitreoretinal lymphoma under an FDA expanded access program, according to a press release.

EyePoint Pharmaceuticals completed enrollment in the phase 2 PAVIA clinical trial to assess EYP-1901 for the treatment of moderate to severe nonproliferative diabetic retinopathy, according to a press release.

A study using a sample size of more than 3 million individuals found no evidence of an association between the mRNA COVID-19 vaccination and new-encounter diagnoses of retinal vascular occlusion.

Norlase secured $11 million in funding following the FDA clearance and CE mark approval of the Echo green pattern laser photocoagulator, according to a press release.

Ray Therapeutics has closed an oversubscribed $100 million Series A financing round to advance the company’s optogenetic gene therapy programs targeting blinding retinal diseases, according to a press release.

NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Arshad M. Khanani, MD, MA, discusses the PRISM trial evaluating 4D-150 intravitreal gene therapy for the treatment of wet age-related macular degeneration.

In this Healio Video Perspective from the Vit-Buckle Society annual meeting, Vivienne S. Hau, MD, PhD, discusses a panel exploring the experiences of LGBTQ physicians.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at the Eyecelerator 2023 with five special guests to discuss the future and developments in eye care.

NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Durga S. Borkar, MD, MMCi, discusses Verana Health’s Qdata module for geographic atrophy.

A single injection of UBX1325 helped patients with diabetic macular edema achieve improved best corrected visual acuity, according to a press release from Unity Biotechnology.